v3.25.2
Changes in Stockholders' Equity - Summary of Reconciliation of Changes in Stockholders Equity (Detail) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Feb. 06, 2025
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Equity          
Beginning balance   $ 207,128 $ 115,577 $ 126,589 $ 109,588
Issuance of common stock upon exercise of stock options   1,116 8 $ 1,443 68
Issuance of common stock upon exercise of stock options (in shares)       1,594,598  
Issuance of common stock upon exercise of common stock warrants   67   $ 733  
Vesting of Promote Sponsor Vesting Shares $ 32,900     32,946 0
Capitalization of offering costs to equity upon share issuance   (888) (80) (888) (132)
Stock-based compensation   3,554 3,287 7,728 6,278
Foreign currency translation gain (loss)   156 (17) (29) (105)
Change in unrealized gain on available-for-sale securities   65 2 57 (16)
Net Income (Loss)   (39,654) (12,421) 2,965 (33,194)
Ending balance   553,263 122,158 553,263 122,158
Common Stock Purchase Agreement          
Equity          
Proceeds from sale of common stock         $ 12,838
Proceeds from sale of common stock (in shares)         10,056,799
Private Placement          
Equity          
Proceeds from sale of common stock   35,000   35,000  
At The Market Offering Agreement          
Equity          
Proceeds from sale of common stock   346,719 $ 15,802 346,719 $ 26,833
Proceeds from sale of common stock (in shares)     12,777,393   19,423,375
Common Stock          
Equity          
Beginning balance   $ 29 $ 16 $ 29 $ 14
Beginning balance (in shares)   286,975,000 165,311,000 283,547,000 147,066,000
Issuance of common stock upon exercise of stock options (in shares)   1,297,000 31,000 1,595,000 250,000
Issuance of common stock upon exercise of common stock warrants (in shares)   10,000   56,000  
Issuance of common stock upon release of restricted stock units ("RSUs") (in shares)   2,150,000 1,478,000 5,234,000 2,801,000
Ending balance   $ 32 $ 17 $ 32 $ 17
Ending balance (in shares)   323,762,000 179,597,000 323,762,000 179,597,000
Common Stock | Common Stock Purchase Agreement          
Equity          
Proceeds from sale of common stock         $ 1
Proceeds from sale of common stock (in shares)         10,057,000
Common Stock | Private Placement          
Equity          
Proceeds from sale of common stock (in shares)   3,020,000   3,020,000  
Common Stock | At The Market Offering Agreement          
Equity          
Proceeds from sale of common stock   $ 3 $ 1 $ 3 $ 2
Proceeds from sale of common stock (in shares)   30,310,000 12,777,000 30,310,000 19,423,000
Additional Paid-In Capital          
Equity          
Beginning balance   $ 719,315 $ 489,955 $ 681,202 $ 463,089
Issuance of common stock upon exercise of stock options   1,116 8 1,443 68
Issuance of common stock upon exercise of common stock warrants   67   733  
Vesting of Promote Sponsor Vesting Shares       32,946  
Capitalization of offering costs to equity upon share issuance   (888) (80) (888) (132)
Stock-based compensation   3,554 3,287 7,728 6,278
Ending balance   1,104,880 508,971 1,104,880 508,971
Additional Paid-In Capital | Common Stock Purchase Agreement          
Equity          
Proceeds from sale of common stock         12,837
Additional Paid-In Capital | Private Placement          
Equity          
Proceeds from sale of common stock   35,000   35,000  
Additional Paid-In Capital | At The Market Offering Agreement          
Equity          
Proceeds from sale of common stock   346,716 15,801 346,716 26,831
Accumulated Other Comprehensive Income (loss)          
Equity          
Beginning balance   (88) 138 105 244
Foreign currency translation gain (loss)   156 (17) (29) (105)
Change in unrealized gain on available-for-sale securities   65 2 57 (16)
Ending balance   133 123 133 123
Accumulated Deficit          
Equity          
Beginning balance   (512,128) (374,532) (554,747) (353,759)
Net Income (Loss)   (39,654) (12,421) 2,965 (33,194)
Ending balance   $ (551,782) $ (386,953) $ (551,782) $ (386,953)